Notable locks in $40 mln Series B
Notable, a provider of a clinically validated AI platform focused on cancer drug development, has raised $40 million in Series B funding. B Capital Group and LifeForce led the round.
16 July 2019•1 min read
Notable, a provider of a clinically validated AI platform focused on cancer drug development, has raised $40 million in Series B funding. B Capital Group and LifeForce led the round.
